Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IMI (Inverness Medical Innovations) litigation: Quidel distances itself from Acon ruling

This article was originally published in Clinica

Executive Summary

Rapid test maker Quidel has insisted there is everything still to play for in its patent litigation against Inverness Medical Innovations. The company issued its statement following the news that Acon Laboratories is facing an injunction on some of its test products after it failed to invalidate a patent owned by Inverness Medical Innovations that is also a key factor in Quidel's litigation.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts